Chat with us, powered by LiveChat

 Speaker Profile

M.D., MBA, Founding Co-Director of Neurovascular Center, USC

Biography
David S. Liebeskind, MD, FAHA, FAAN is Professor of Neurology at the University of California, Los Angeles (UCLA) where he serves as the Associate Neurology Director of the UCLA Stroke Center and the Neurology Director of the Stroke Imaging Program. He is Co-Director of the UCLA Cerebral Blood Flow Laboratory and Director of the UCLA Vascular Neurology Residency Program. He trained in chemical engineering at Columbia University and completed his MD at New York University School of Medicine. Postgraduate medical training included internship at Beth Israel Hospital, Boston and neurology residency at UCLA. After his residency, he completed a fellowship in stroke and cerebrovascular disease at UCLA and subsequently joined the faculty in the Departments of Neurology and Radiology at the University of Pennsylvania. He has maintained extensive clinical activity across a broad range of cerebrovascular disorders ranging from carotid disease to unusual causes of stroke. Clinical expertise includes cerebral venous thrombosis, arterial dissection, moyamoya syndrome and other causes of stroke in the young. His principal research interests include novel neuroimaging approaches to elucidate fundamental pathophysiologic correlates of cerebrovascular disease in humans with a particular focus on the collateral circulation. His work on collateral perfusion in acute ischemic stroke draws on advances in noninvasive, multimodal CT and MRI and detailed analyses of digital subtraction angiography. He directs an angiography and imaging core laboratory that has participated in central readings of MERCI, Multi MERCI, IMS-III, TREVO EU and TREVO 2. His research on collaterals in intracranial atherosclerosis complements his work on acute stroke, utilizing computational fluid dynamic modeling and estimates of fractional flow to predict risk of ischemia and reperfusion hemorrhage.


 Session Abstract – PMWC 2027 Silicon Valley

Showcase Track S2 - Jan 27 11.30 A.M.-2.30 P.M.,Showcase Track S2 - Jan 28 1.00 P.M.-2.00 P.M.,Showcase Track S1 - Jan 29 2.45 P.M.-1.45 P.M.


Davos of Precision Medicine

PMWC 2027 Program

January 27–29, 2027 · Santa Clara Convention Center

Swipe speakers · Tap a card for sessions →

What the PMWC community says
PMWC is indeed The Davos of Biotech
Brook ByersFounderKleiner Perkins

Preparing the full agendaFive scientific tracks. Three days of discovery.

PMWC Hall of Impact

Previous Speakers Include

Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.

×

Add Names/PO on Receipt

Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Save $1176 By OCT. 22
PMWC 2027 Jan. 27-29 • Santa Clara
15 tracks • 400 speakers Co-hosted by Stanford/UCSF/Yale • Davos of PM
SAVE $1176 Rate increases OCT. 22 LOCK IN RATE

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required

Apply to Speak at PMWC Silicon Valley by OCT. 22ND

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.